DRUG SAFETY COMMUNICATION: FDA REQUIRESWARNINGS ABOUT INCREASED RISK OF SERIOUSHEART-RELATED EVENTS, CANCER, BLOOD CLOTS,AND DEATH FOR JAK INHIBITORS THAT TREATCERTAIN CHRONIC INFLAMMATORY CONDITIONS

Medical Information
United States
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

InformaciĆ³n selecta para pacientes y cuidadores que se encuentra disponible en EspaƱol.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?